PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Sickle Cell 17,551 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.62
Infection 766,637 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.54
Anxiety 113,510 Disease Target Tachykinin Receptor 1 13 2 0.00 -0.92 0.15 0.59
Cholesterol 182,390 Disease Target Glutathione Peroxidase 6 13 1 0.00 -0.96 0.08 0.57
Aralen (Chloroquine)- FDA 19 Drug Drug Acitretin (Soriatane)- FDA 13 2 0.13 -0.87 0.15 0.88
Thromboembolic Disease 3,336 Disease Drug Angiomax (Bivalirudin)- FDA 13 1 0.00 -0.96 0.08 0.66
Diabetes 332,602 Disease Disease Nephropathy Diabetic 13 9 0.00 -0.55 0.69 0.60
Obesity 138,233 Disease Drug Alpha (Prolastin)- FDA 13 1 0.00 -0.96 0.08 0.57
Acute Coronary Syndromes 9,133 Disease Drug Angiomax (Bivalirudin)- FDA 13 5 0.01 -0.78 0.38 0.68
Renin 43,456 Target Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.60
Deep Vein Thrombosis 10,952 Disease Drug Angiomax (Bivalirudin)- FDA 13 1 0.00 -0.96 0.08 0.63
Analgesia 44,857 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.60
Alefacept (Amevive)- FDA 21 Drug Drug Acitretin (Soriatane)- FDA 13 1 0.06 -0.94 0.08 0.84
Panic Disorder 7,455 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.64
Hearing Loss 30,622 Disease Target Glutathione Peroxidase 6 13 2 0.00 -0.92 0.15 0.62
Cancer 1,053,491 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.53
Arthritis 128,324 Disease Drug Acitretin (Soriatane)- FDA 13 4 0.00 -0.83 0.31 0.60
Depression 220,092 Disease Drug Acitretin (Soriatane)- FDA 13 1 0.00 -0.96 0.08 0.56
Seizure 44,685 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.60
Carcinoma 433,099 Disease Target AMY1A 13 1 0.00 -0.96 0.08 0.55
Thrombocytopenia 35,805 Disease Drug Angiomax (Bivalirudin)- FDA 13 6 0.01 -0.73 0.46 0.65
Alitretinoin (Panretin)- FDA 7 Drug Drug Acitretin (Soriatane)- FDA 13 1 0.10 -0.89 0.14 0.87
Renin 43,456 Target Target AMY1A 13 1 0.00 -0.96 0.08 0.60
Thromboembolism 23,698 Disease Drug Angiomax (Bivalirudin)- FDA 13 3 0.01 -0.88 0.23 0.64
Glutathione Peroxidase 3 132 Target Target Glutathione Peroxidase 6 13 1 0.02 -0.96 0.08 0.76
Adalimumab (Humira)- FDA 62 Drug Drug Acitretin (Soriatane)- FDA 13 1 0.04 -0.95 0.08 0.79
Bronchitis 18,336 Disease Drug Alpha (Prolastin)- FDA 13 2 0.00 -0.92 0.15 0.63
Depression 220,092 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.56
Adenosine A1 Receptor 1,432 Target Target Sulfonylurea Receptor 2b 13 1 0.01 -0.96 0.08 0.69
Attention Deficit Hyperactivity Disorder 14,687 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.62
Androgen Receptor 12,918 Target Target Sulfonylurea Receptor 2b 13 1 0.00 -0.96 0.08 0.63
Infection 766,637 Disease Target Glutathione Peroxidase 6 13 1 0.00 -0.96 0.08 0.54
Migraine 24,200 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.61
Aggression 20,035 Disease Target Tachykinin Receptor 1 13 1 0.00 -0.96 0.08 0.62
Stroke 146,992 Disease Drug Angiomax (Bivalirudin)- FDA 13 2 0.00 -0.92 0.15 0.59
Bipolar Affective Disorder 1,690 Disease Target Tachykinin Receptor 1 13 1 0.01 -0.96 0.08 0.68
Brain Injury 34,874 Disease Target ATF-2 Protein 13 1 0.00 -0.96 0.08 0.60
Thrombocytopenia 35,805 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 2 0.00 -0.91 0.17 0.62
Hyperglycemia 28,168 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.61
Cholesterol 182,390 Disease Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.57
Chronic Lymphocytic Leukemia 11,642 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.63
Leukemia 162,805 Disease Drug Arranon (Nelarabine)- FDA 12 9 0.01 -0.50 0.75 0.62
Tuberculosis 146,217 Disease Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.57
Leukemias 14,152 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.63
Brain Tumors 16,749 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.62
Anemia 81,663 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.58
Pain 409,851 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.55
Seizures 66,465 Disease Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.59
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
Nausea 42,627 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 2 0.00 -0.91 0.17 0.62
Cancer 1,053,491 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 3 0.00 -0.87 0.25 0.56
Diarrhea 51,986 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.59
Infection 766,637 Disease Disease Leprosy Lepromatous 12 2 0.00 -0.91 0.17 0.55
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
CD4 112,219 Target Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.58
Shock 134,031 Disease Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.57
Cancer 1,053,491 Disease Drug Arranon (Nelarabine)- FDA 12 2 0.00 -0.91 0.17 0.55
Breast Cancer 173,695 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.57
Hepatitis 163,842 Disease Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.57
Infection 766,637 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 1 0.00 -0.96 0.08 0.54
Neutropenia 25,934 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 4 0.01 -0.82 0.33 0.64
CD22 1,591 Target Drug Arranon (Nelarabine)- FDA 12 1 0.01 -0.96 0.08 0.68
CD4 112,219 Target Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.58
Glucocorticoid Receptor 10,306 Target Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.63
Malaria 56,215 Disease Drug Atovaquone (Mepron)- FDA 11 3 0.00 -0.85 0.27 0.62
Diabetes 332,602 Disease Target ADSF 11 3 0.00 -0.85 0.27 0.58
Cancer 1,053,491 Disease Drug Aphrodyne (Yohimbine)- FDA 11 2 0.00 -0.90 0.18 0.55
Depression 220,092 Disease Drug Atropen (Atropine)- FDA 11 1 0.00 -0.95 0.09 0.57
Epilepsy 71,172 Disease Disease Seizures Partial 11 6 0.01 -0.67 0.55 0.63
Akineton (Biperiden)- FDA 1 Drug Drug Atropine (Atropen)- FDA 11 1 0.30 -0.68 1.00 0.88
Pneumonia 81,521 Disease Drug Atovaquone (Mepron)- FDA 11 5 0.01 -0.74 0.45 0.62
Nausea 42,627 Disease Drug Atropine (Atropen)- FDA 11 1 0.00 -0.95 0.09 0.60
Stroke 146,992 Disease Drug Atovaquone (Mepron)- FDA 11 1 0.00 -0.95 0.09 0.57
Hyperglycemia 28,168 Disease Disease Seizures Partial 11 1 0.00 -0.95 0.09 0.61
Seizure 44,685 Disease Disease Seizures Partial 11 3 0.00 -0.85 0.27 0.63
Sepsis 64,798 Disease Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.59
Osteoarthritis 36,287 Disease Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.60
Fracture 111,575 Disease Target ADSF 11 1 0.00 -0.95 0.09 0.58
Obesity 138,233 Disease Target ADSF 11 2 0.00 -0.90 0.18 0.59
Nausea 42,627 Disease Drug Atropen (Atropine)- FDA 11 1 0.00 -0.95 0.09 0.60
CD4 112,219 Target Drug Atovaquone (Mepron)- FDA 11 1 0.00 -0.95 0.09 0.58
Aspergillosis 9,759 Disease Drug Anidulafungin (Eraxis)- FDA 11 3 0.01 -0.85 0.27 0.66
Depression 220,092 Disease Drug Atropine (Atropen)- FDA 11 1 0.00 -0.95 0.09 0.57
Cancer 1,053,491 Disease Drug Anidulafungin (Eraxis)- FDA 11 1 0.00 -0.95 0.09 0.54
Prostate Cancer 71,064 Disease Drug Aphrodyne (Yohimbine)- FDA 11 2 0.00 -0.90 0.18 0.60
Atropine (Atropen)- FDA 11 Drug Drug Atropen (Atropine)- FDA 11 11 1.00 -0.08 1.00 1.00
Akineton (Biperiden)- FDA 1 Drug Drug Atropen (Atropine)- FDA 11 1 0.30 -0.68 1.00 0.88
CD34 24,598 Target Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.61
Atosiban 274 Target Drug Atropen (Atropine)- FDA 11 1 0.02 -0.95 0.09 0.74
Azithromycin (Zithromax)- FDA 36 Drug Drug Atovaquone (Mepron)- FDA 11 1 0.05 -0.94 0.09 0.82
Candidemia 1,512 Disease Drug Anidulafungin (Eraxis)- FDA 11 3 0.02 -0.85 0.27 0.72
Leukemia 162,805 Disease Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.57
CEA 17,022 Target Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.62
Poisoning 53,779 Disease Drug Atropine (Atropen)- FDA 11 5 0.01 -0.74 0.45 0.63
Anxiety 113,510 Disease Disease Seizures Partial 11 1 0.00 -0.95 0.09 0.58
Coma 24,208 Disease Drug Atropen (Atropine)- FDA 11 1 0.00 -0.95 0.09 0.61
Atridox (Doxycycline Hyclate)- FDA 38 Drug Drug Atovaquone (Mepron)- FDA 11 2 0.10 -0.88 0.18 0.84
Neutropenia 25,934 Disease Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.61
Poisoning 53,779 Disease Drug Atropen (Atropine)- FDA 11 5 0.01 -0.74 0.45 0.63
Atropine (Atropine)- FDA 13 Drug Drug Atropine (Atropen)- FDA 11 11 0.92 -0.13 1.00 0.99